Halsey Details Undergoing Chemo for Rare Disorder in Life Update | E! News

    Just did another few sessions of chemo. Had a new port place. Hoy is getting candid about her health journey. In 2024, the singer shared her diagnosis with lupus and a rare T-C cell lympho proliferative disorder, which is an umbrella term for diseases related to the overprouction of white blood cells. And in a September 25th Tik Tok, Hollyy shows off the port and medical tape on her collar bone and chest. Users chimed into the comments with plenty of questions and thoughts. One fan said her husband does the same kind of treatment for lupus and blood cancer and as a result he gets wiped and can’t stand for a week. She asks, “How do you find the energy for your shows?” Holly replies with, “I also can’t stand for like a week or more. You guys see me between treatment where I have energy. The time flies by when I’m recovering, so it doesn’t seem like as long, but it’s definitely a while.” And then she adds, “Shout out to your husband and sharing dual diagnosis with me. Much love to both of you.

    Halsey shared a rare update on her life, including undergoing chemotherapy for treating her lupus and T-cell lymphoproliferative disorder alongside preparing for her upcoming tour. Full Story: https://www.eonline.com/news/1423049/halsey-details-undergoing-chemotherapy

    #enews #halsey #chemotherapy

    About:
    The E! News team brings you the latest breaking entertainment, fashion and Pop Culture news. Featuring exclusive segments, celebrity highlights, trend reports and more, the E! News channel is the only destination Pop Culture fans need to stay in the know. Subscribe here: http://bit.ly/enewssub

    Connect:
    For More News – https://eonline.us/3MASskW
    E! News App – https://eonline.onelink.me/yMtl/4ead5017
    Shopping – https://eonline.com/news/shop
    Facebook – https://www.facebook.com/enews/
    Instagram – https://www.instagram.com/enews/
    X – https://x.com/enews/
    TikTok – https://tiktok.com/@enews

    Share.

    1 Comment

    Leave A Reply